Correction: The kick-in system: a novel rapid knock-in strategy (PLoS ONE (2014) 9, 2 (e88549) DOI: 10.1371/journal.pone.0088549);The kick-in system: A novel rapid knock-in strategy

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Tomonoh, Yuko ^a   Deshimaru, Masanobu ^a   Araki, Kimi ^b   Miyazaki, Yasuhiro ^a   Arasaki, Tomoko ^a   Tanaka, Yasuyoshi ^a   Kitamura, Haruna ^a   Mori, Fumiaki ^c   Wakabayashi, Koichi ^c   Yamashita, Sayaka ^a   Saito, Ryo ^a   Itoh, Masayuki ^d   Uchida, Taku ^a   Yamada, Junko ^c   Migita, Keisuke ^c   Ueno, Shinya ^c   Kitaura, Hiroki ^e   Kakita, Akiyoshi ^e   Lossin, Christoph ^f   Takano, Yukio ^a   Hirose, Shinichi ^a   more..

^a FUKUOKA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PENTETRAZOLE; POTASSIUM CHANNEL KCNQ2; PROTEIN C FOS;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN FAMILIAL NEONATAL EPILEPSY; CELL MANIPULATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; EPILEPSY; EPILEPTOGENESIS; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC VARIABILITY; HETEROZYGOTE; HIPPOCAMPAL CA1 REGION; HOMOZYGOTE; KICK IN SYSTEM; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PYRAMIDAL NERVE CELL; SEIZURE; ANIMAL; ANIMAL BEHAVIOR; BENIGN CHILDHOOD EPILEPSY; CHEMICALLY INDUCED; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; PREGNANCY; PROCEDURES; TIME;

ANIMALS; BEHAVIOR, ANIMAL; EMBRYONIC STEM CELLS; EPILEPSY, BENIGN NEONATAL; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; HUMANS; KCNQ2 POTASSIUM CHANNEL; MALE; MICE; MUTATION; PENTYLENETETRAZOLE; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; TIME FACTORS;

EID: 84896775791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106125     Document Type: Erratum

References (30)

1. Hirose S, Mitsudome A, Okada M, Kaneko S, Epilepsy Genetic Study Group J (2005) Genetics of idiopathic epilepsies. Epilepsia 46 Suppl 1: 38-43. (Pubitemid 40365626)
2. Kaneko S, Okada M, Iwasa H, Yamakawa K, Hirose S (2002) Genetics of epilepsy: current status and perspectives. Neurosci Res 44: 11-30. (Pubitemid 36158699)
3. Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M (1993) Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 43: 1355-1360. (Pubitemid 23213809)
4. Vigevano F (2005) Benign familial infantile seizures. Brain Dev 27: 172-177.
5. Dedek K, Fusco L, Teloy N, Steinlein OK (2003) Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res 54: 21-27. (Pubitemid 36556194)
6. Borgatti R, Zucca C, Cavallini A, Ferrario M, Panzeri C, et al. (2004) A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology 63: 57-65. (Pubitemid 38943779)
7. Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, et al. (2012) KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol 71: 15-25.
8. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18: 25-29. (Pubitemid 28027874)
9. Singh NA, Otto JF, Dahle EJ, Pappas C, Leslie JD, et al. (2008) Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol 586: 3405-3423. (Pubitemid 352003874)
10. Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, et al. (1993) A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem 214: 70-76. (Pubitemid 23300355)
11. Araki K, Araki M, Yamamura K (2002) Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. Nucleic Acids Res 30: e103.
12. Berger SL, Chirgwin JM (1989) Isolation of RNA. Methods Enzymol 180: 3-13. (Pubitemid 20039561)
13. Luttjohann A, Fabene PF, van Luijtelaar G (2009) A revised Racine's scale for PTZ-induced seizures in rats. Physiol Behav 98: 579-586.
14. Otto JF, Yang Y, Frankel WN, White HS, Wilcox KS (2006) A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons. J Neurosci 26: 2053-2059.
15. Araki K, Okada Y, Araki M, Yamamura K (2010) Comparative analysis of right element mutant lox sites on recombination efficiency in embryonic stem cells. BMC Biotechnol 10: 29.
16. Araki K, Araki M, Yamamura K (1997) Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res 25: 868-872. (Pubitemid 27299845)
17. Dymecki SM (1996) Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci U S A 93: 6191-6196.
18. McLeod M, Craft S, Broach JR (1986) Identification of the crossover site during FLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle. Mol Cell Biol 6: 3357-3367.
19. VanElzakker M, Fevurly RD, Breindel T, Spencer RL (2008) Environmental novelty is associated with a selective increase in Fos expression in the output elements of the hippocampal formation and the perirhinal cortex. Learn Mem 15: 899-908.
20. Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29: 261-265. (Pubitemid 19222725)
21. Abremski K, Hoess R, Sternberg N (1983) Studies on the properties of P1 site-specific recombination: evidence for topologically unlinked products following recombination. Cell 32: 1301-1311. (Pubitemid 13033058)
22. Sauer B (1998) Inducible gene targeting in mice using the Cre/lox system. Methods 14: 381-392.
23. Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, et al. (1987) Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330: 576-578. (Pubitemid 17164356)
24. Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-170.
25. Wefers B, Meyer M, Ortiz O, Hrabe de Angelis M, Hansen J, et al. (2013) Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci U S A 110: 3782-3787.
26. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, et al. (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-918.
27. Blumkin L, Suls A, Deconinck T, De Jonghe P, Linder I, et al. (2012) Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation. Eur J Paediatr Neurol 16: 356-360.
28. Otto JF, Singh NA, Dahle EJ, Leppert MF, Pappas CM, et al. (2009) Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions. Epilepsia 50: 1752-1759.
29. Watanabe H, Nagata E, Kosakai A, Nakamura M, Yokoyama M, et al. (2000) Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 75: 28-33. (Pubitemid 30418165)
30. Schroeder BC, Kubisch C, Stein V, Jentsch TJ (1998) Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K + channels causes epilepsy. Nature 396: 687-690. (Pubitemid 29003948)